Holocene Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,198,298
| Closed | -$100M | – | 918 |
|
|
2024
Q4 | $100M | Sell |
1,198,298
-172,533
| -13% | -$14.4M | 0.32% | 87 |
|
|
2024
Q3 | $100M | Sell |
1,370,831
-108,844
| -7% | -$7.96M | 0.41% | 81 |
|
|
2024
Q2 | $101M | Buy |
1,479,675
+570,585
| +63% | +$39.1M | 0.42% | 77 |
|
|
2024
Q1 | $62.9M | Sell |
909,090
-352,767
| -28% | -$24.4M | 0.23% | 136 |
|
|
2023
Q4 | $90.4M | Sell |
1,261,857
-170,659
| -12% | -$12.2M | 0.35% | 99 |
|
|
2023
Q3 | $74.6M | Sell |
1,432,516
-263,292
| -16% | -$13.7M | 0.33% | 93 |
|
|
2023
Q2 | $107M | Buy |
1,695,808
+579,544
| +52% | +$36.7M | 0.46% | 72 |
|
|
2023
Q1 | $60.4M | Sell |
1,116,264
-614,829
| -36% | -$33.3M | 0.3% | 105 |
|
|
2022
Q4 | $91.6M | Buy |
1,731,093
+139,710
| +9% | +$7.39M | 0.56% | 60 |
|
|
2022
Q3 | $74M | Sell |
1,591,383
-36,025
| -2% | -$1.68M | 0.47% | 73 |
|
|
2022
Q2 | $92.9M | Buy |
1,627,408
+904,684
| +125% | +$51.6M | 0.56% | 55 |
|
|
2022
Q1 | $44.2M | Buy |
+722,724
| New | +$44.2M | 0.23% | 130 |
|